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Background & aims: Eating habits may influence the life span and the quality of ageing process by
modulating inflammation. The RISTOMED project was developed to provide a personalized and balanced
diet, enriched with or without nutraceutical compounds, to decrease and prevent inflammageing,
oxidative stress and gut microbiota alteration in healthy elderly people. This paper focused on the effect
on inflammation and metabolism markers after 56 days of RISTOMED diet alone or supplementation
with three nutraceutical compounds.
Methods: A cohort of 125 healthy elderly subjects was recruited and randomized into 4 arms (Arm A,
RISTOMED diet; Arm B, RISTOMED diet plus VSL#3 probiotic blend; Arm C, RISTOMED diet plus AISA d-
Limonene; Arm D, RISTOMED diet plus Argan oil). Inflammatory and metabolism parameters as well as
the ratio between Clostridium cluster IV and Bifidobacteria (CL/B) were collected before and after 56 days
of dietary intervention, and their evolution compared among the arms. Moreover, participants were
subdivided according to their baseline inflammatory parameters (erythrocytes sedimentation rate (ESR),
C-Reactive Protein, fibrinogen, Tumor Necrosis Factor-alfa (TNF-a), and Interleukin 6) in two clusters
with low or mediumehigh level of inflammation. The evolution of the measured parameters was then
examined separately in each cluster.
Results: Overall, RISTOMED diet alone or with each nutraceutical supplementation significantly
decreased ESR. RISTOMED diet supplemented with d-Limonene resulted in a decrease in fibrinogen,
glucose, insulin levels and HOMA-IR. The most beneficial effects were observed in subjects with a me-
diumehigh inflammatory status who received RISTOMED diet with AISA d-Limonene supplementation.
Moreover, RISTOMED diet associated with VSL#3 probiotic blend induced a decrease in the CL/B ratio.CT01069445eNCT01179789.
io).
for Clinical Nutrition and Metabolism.
t al., Impact of diet and nutraceutical supplementation on inflammation in elderly people. Results
ndomized control trial, Clinical Nutrition (2015), http://dx.doi.org/10.1016/j.clnu.2015.06.010
R. Ostan et al. / Clinical Nutrition xxx (2015) 1e72Please cite this article in press as: Ostan R, e
from the RISTOMED study, an open-label raConclusions: Overall, this study emphasizes the beneficial anti-inflammageing effect of RISTOMED diet
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One of the typical aspects of the ageing process is the devel-
opment of a low grade inflammatory status called “inflammageing”
which plays a critical role in the pathogenesis of the main age-
related chronic diseases as Parkinson's and Alzheimer's diseases,
type 2 diabetes, atherosclerosis, sarcopenia and cancer [1e3].
This inflammatory status includes a profound modification
within the cytokine network leading to a general increase in plasma
levels and cell capability to produce pro-inflammatory cytokines
with a subsequent increase of the main inflammatory markers [4].
Inflammageing is the result of a dynamic signaling produced by
different organs and tissues. In particular, adipose tissue has been
recognized as an active endocrine organ able to regulate physio-
logical and pathological processes, such as immunity and inflam-
mation, through the production of pro-inflammatory and anti-
inflammatory factors, including cytokines (Interleukin-6, IL-6 and
Tumor Necrosis Factor-alpha, TNF-a), adipokines (leptin, adipo-
nectin and resistin), and chemokines. The aging process is physio-
logically associated with a lean body mass loss leading to an
increase in fat mass percentage on body weight, specifically in the
abdominal region [5]. In this context, anti-inflammatory strategies
may be useful to prevent or delay ageing and the onset of age-
related diseases [6].
The excessive intake of energy and nutrients together with the
kind of nutrients consumed may turn on inflammatory pathways,
directly or indirectly, through different mechanisms such as the
induction of obesity and endoplasmic reticulum stress. In partic-
ular, dietary fatty acids may affect inflammatory processes notably
through modulation of the metabolism of eicosanoids and of the
expression of inflammatory cytokines through a series of tran-
scriptional events mediated by NF-kB. Moreover, sugars and car-
bohydrates stimulate pancreatic islets and insulin-sensitive tissues
such as adipose tissue, liver and muscles [7e9]. Conversely,
malnutrition and, in particular, a diet with insufficient protein
intake, is associated with frailty, decline in functional status,
impaired muscle function, decreased bone mass, immune
dysfunction, reduced cognition and mortality [9e11].
For all these reasons, assessment of the adequate dietary
requirement and administration of the correct nutritional intake
could be a fundamental issue to maintain or restore health in
advanced age.
The European project RISTOMED (www.ristomed.eu), a multi-
center ‘open-label’ randomized study (CORDIS FP7), was designed
to develop and provide a healthy, personalized and balanced di-
etary intervention, enriched or not with specific nutraceutical
compounds, to decrease and prevent inflammageing, oxidative
stress and gut microbiota alteration in healthy elderly people.
RISTOMED diet was built to reach the recommended daily
requirement of nutrients, vitamins and minerals complying with
different cultural patterns. RISTOMED diet was designed with a
particular attention towards those foods and nutrients known or
suspected to be able to reduce inflammation and oxidative stress by
promoting a healthy gut microbiota in elderly people [12].
The aim of this study was to investigate the effect of RISTOMED
diet supplemented or not with nutraceuticals on inflammageing
and other critical processes (oxidative stress and gut microbiotat al., Impact of diet and nutra
ndomized control trial, Clinicalteration) in elderly healthy people, taking into account that the
health of gut microbiota is associated with the immune function-
ality [13]. The primary outcome was the decrease of hsCRP (high-
sensitivity C-reactive protein) levels in each study arm. HsCRP was
selected as primary outcome because it is an internationally
recognized marker of inflammation and cardiovascular risk [14,15].
Secondary outcomes included other markers of inflammatory and
metabolic status, oxidative stress, gut microbiota composition as
well as quality of life and physical performance.
In the present paper, we report some results of the RISTOMED
study, focusing on the effect of RISTOMED diet alone or with three
nutraceutical compounds, namely a probiotic blend, an orange peel
extract containing d-Limonene and Argan oil, on inflammatory and
metabolic markers in healthy elderly subjects.2. Materials and methods
2.1. Recruitment
It was planned to recruit 144 elderly subjects (age 65e85 years
old, equal number of males and females) in three European cities
(Rome, Italy; Bordeaux, France; Berlin, Germany), between May
2009 and April 2010, according to strict inclusion and exclusion
criteria. Body Mass Index (BMI) was to be in the range of 22e30 kg/
m2, in the absence of known diseases (neurologic or psychiatric
disorder, geriatric anorexia, active infection, constipation and
gastric disease requiring medical therapy, chronic inflammatory
bowel disease, diabetes mellitus, dyslipidemia and/or other meta-
bolic diseases, neoplasms). The subjects should not receive any
chronic anti-inflammatory therapy such as NSAIDs nor any other
kind of therapy in the 20 days before the beginning of the study.
Participants had to use no food supplements or functional foods
such as probiotics, prebiotics, vitamins and minerals in the week
before the beginning of the study. Moreover, the subjects had to be
able to comply with management of nutraceutical products, to use
a computer and to access the web, by themselves or with the help
of a caregiver. The study protocol was approved by the ethics
committee at each recruiting institution and the participants gave
written informed consent at enrollment. The study was registered
at ClinicalTrials.gov as NCT01069445eNCT01179789, and was
conducted under the 7th Framework Program of the European
Commission.
After obtaining informed consent, the subjects were random-
ized into 4 arms: Arm A received the RISTOMED diet alone, Arm B
received the RISTOMED diet supplemented with the VSL#3 pro-
biotic blend, Arm C received the RISTOMED diet supplemented
with the AISA-5203-L fruit peel extracted monoterpene d-Limo-
nene, ArmD received the RISTOMED diet supplementedwith Argan
Oil. Randomization was performed centrally and stratified by
recruitment center and gender as described elsewhere [12]. The
study was conducted in accordance with International Good Clin-
ical Practice guidelines (ICH, May 1977), the Declaration of Helsinki,
and national laws and regulations.
All subjects were evaluated before starting the study (D0) and
after a period of 56 ± 2 days of diet with or without supplemen-
tation (D56). A fasting venous blood sample and stools wereceutical supplementation on inflammation in elderly people. Results
al Nutrition (2015), http://dx.doi.org/10.1016/j.clnu.2015.06.010
Fig. 1. Flow chart of participants of the RISTOMED project.
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(D56).2.2. Diet
The RISTOMED diet was personalized by a dietician using the
RISTOMED-Health dietary Services (www.ristomed.eu) [12]. Each
participant received a personal login to the RISTOMEDwebsite, and
was trained by a dietician to get the personalized diet from the web
platform. Recipes and daily menus were formulated taking into
account traditional and personal eating habits. The nutritional
pattern was established in agreement with the current dietary
recommendations for elderly people, specific attention being given
to the intake of food compounds that can affect inflammation,
oxidative stress and gut microbiota [i.e. Poly Unsaturated Fatty
Acidse PUFA n-6/n-3 ratioe antioxidant vitamins (vitamin E, C and
carotenoids) and minerals (zinc and selenium), polyphenols and
soluble dietary fiber].
The RISTOMED diet provided ~15% of energy as proteins,
50e60% as carbohydrates and ~35% as lipids. The latter were
15e20% Mono-Unsaturated Fatty Acids (MUFA), provided by virgin
olive oil, ~8% Saturated Fatty Acids (SFA) and ~7% PUFAwith 0.5% a-
linolenic acid and 2% linoleic acid. The daily recommended intake
of uncooked Argan oil (25mL), when required in the study arm,was
given in partial replacement of an equal amount of extra-virgin
olive oil. Dietary fiber intake was ~35 g/day with an insoluble/sol-
uble fiber ratio of around 1:1, related to the prebiotic activity
generally assigned to soluble fiber [16]. Polyphenols' intake was
established at 400 mg/day (as phenolic acids plus flavonoids;Table 1
Drop out for each arm of dietary intervention.
No compliance
Arm A n ¼ 1
Arm B n ¼ 1
Arm C n ¼ 0
Arm D n ¼ 1
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from the RISTOMED study, an open-label randomized control trial, Clinic[17]). The intake of vitamins and minerals was referenced to the
WHO program “Keep fit for life” [18]. The minimumwater need for
elderly people is 1e1.5 mL/kcal/day and it was recommended to use
a calcium-rich water (Ca  150 mg/L).
On the website, participants recorded their weight weekly and
described the compliance to the diet and to the nutraceutical
supplementation daily. After 2 and 6 weeks (D14 and D42) from the
beginning of the intervention, the nutritionist/dietician contacted
by phone each participant to verify his/her compliance to the diet
and to the nutraceutical supplementation.2.3. Nutraceutical supplementation
VSL#3 probiotic blend (ACTIAL Farmaceutica Lda) is formulated
as a granulated powder of 112 billion lyophilized bacteria per
capsule in defined ratios of 4 strains of Lactobacillus (Lactobacillus
paracasei, Lactobacillus plantarum, Lactobacillus acidophilus, and
Lactobacillus delbrueckii subsp. bulgaricus), 3 strains of Bifido-
bacterium (Bifidobacterium longum, Bifidobacterium breve, and
Bifidobacterium infantis) and Streptococcus thermophilus. The prod-
uct was administered orally, 2 capsules daily on an empty stomach
with a glass of water.
The monoterpene AISA 5203-L (d-Limonene and its metabo-
lites) extracted from orange peel was administrated orally in soft
gel capsules with a meal and a large glass of water. The daily
number of soft gel capsules was established for each patient ac-
cording to the recommended dose of 10 ± 1 mg/kg.
Argan oil, the extra-virgin oil obtained using a cold-pressed
technique of kernels contained in the Argania spinosa fruit, wasAdverse events
n ¼ 2 (Dental infection e Chest tightness)
n ¼ 3 (Sleep disturbance e Stomach pain e Inflammatory status)
n ¼ 4 (Antibiotic therapy e Sigmoiditis e Nose bleeding e Nausea)
n ¼ 1 (Bowel discomfort)
ceutical supplementation on inflammation in elderly people. Results
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Table 2
Comparison of the baseline characteristic of the recruited subjects among the arms of dietary intervention. Statistical analyses were performed by Student t or Chi Square Test.
Arm A (diet) Arm B (Diet þ VSL#3) Arm C (Diet þ AISA) Arm D (Diet þ Argan oil) p
N 31 31 30 33
Age, mean (SD) 70.5 (4) 69.7 (3.9) 70 (3.8) 71.4 (3.9) NS
Gender, M/F 14/17 15/16 14/16 15/18 NS
BMI, kg/m2 (SD) 26.9 (3.4) 26.7 (3.8) 26.8 (2.8) 26.6 (3.5) NS
R. Ostan et al. / Clinical Nutrition xxx (2015) 1e74supplied in 12.5 mL monodose sachets. The daily recommended
intake was 25 mL taken as twomonodoses per day at each person's
convenience with breakfast, lunch and/or dinner.
2.4. Laboratory analyses
Peripheral blood analyses were performed on whole blood,
serum or plasma collected as described above [12]. Standard clin-
ical laboratory methods or specific ELISA tests were used (Aushon
Biosystems, Billerica, MA; BioVendor, Modrice, Czech Republic;
Mediagnost, Reutlingen, Germany). Inflammatory status was
established using Erythrocytes Sedimentation Rate (ESR), hsCRP,
fibrinogen, TNF-a and IL-6. Since changes in the gut microbiota
composition may be connected with inflammageing, stool samples
were collected on D0 and D56 to measure the ratio between Clos-
tridium cluster IV and Bifidobacteria (CL/B) through 16S rRNA gene-
targeted qPCR [12].
Insulin resistance was assessed by measuring glucose and in-
sulin levels and calculating the HOMA-IR index according to a
previously published formula [19].
2.5. Statistical analyses
The effects of the dietary interventions measured on D56 were
assessed as percentage variations compared to baseline, in order to
minimize individual disparities. After testing for normality, these
percentages of variation were compared between the four arms
with a KruskaleWallis test. Paired Wilcoxon rank sum tests were
used to assess the median percentages of variations for each
parameter between D0 and D56 according to the arm of dietary
intervention.
Two-Step Cluster Analysis was applied to determine 2 groups of
subjects identified as “low inflammation” and “mediumehighFig. 2. Percentages of variation of fibrinogen levels among the arms of dietary inter-
vention. A ¼ RISTOMED diet, B ¼ RISTOMED diet þ VSL#3, C ¼ RISTOMED diet þ AISA,
D ¼ RISTOMED diet þ Argan oil. Statistical analyses were performed by KruskaleWallis
test; *p < 0.05 between arm C and arms A and D.
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described above at baseline. As Two-Step Cluster Analysis assumes
a normal distribution of interval data the parameters were z-
transformed to approximate normality. Baseline comparisons be-
tween the two inflammation clusters were performed using a
Mann Whitney test. KruskaleWallis and paired Wilcoxon tests
were applied as above in each cluster.
All tests were performed using the Medcalc® (bvba, Ostend,
Belgium) software and SPSS/Win program version 19 (Spss Inc.,
Chicago, IL). The level of statistical significance was defined by a
two-tailed p value < 0.05.3. Results
3.1. Global analysis
A total of 125 elderly subjects (mean age 70.4 ± 3.9 yrs, 58 males
and 67 females) were recruited and completed the study. The flow
chart of participants is reported in Fig. 1, drop outs for each arm are
reported in Table 1. No significant differences in age (p¼ 0.550) and
gender distribution (p ¼ 0.568) were found between the three
recruitment centers (data not shown). As shown in Table 2, the four
arms of dietary intervention were comparable in age, gender dis-
tribution and BMI at baseline (D0). Compliance with the intake of
nutraceuticals was between 87% and 95%, between 71% and 80%
and between 81% and 90% for VSL#3, AISA, and Argan Oil respec-
tively in different centers.
The differences between D0 and D56 were compared among the
four arms of dietary intervention.
Although this was the primary outcome expected, hsCRP vari-
ations were not significant either between arms or within each of
them (Arm A, median variation 7.7%, Arm B, 0%, Arm C, 7.1% and
Arm D, 0%, KruskaleWallis test p ¼ 0.86).Fig. 3. Significant percentages of variation of ESR in each arm of dietary intervention.
A ¼ RISTOMED diet, B ¼ RISTOMED diet þ VSL#3, C ¼ RISTOMED diet þ AISA,
D ¼ RISTOMED diet þ Argan oil. Statistical analyses were performed by paired Wil-
coxon test between D0 and D56. p values are reported in the text.
ceutical supplementation on inflammation in elderly people. Results
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Table 3
Percentage of median change from baseline for glucose, HOMA, insulin and CL/B ratio for each dietary arm. Statistical analyses were performed by paired Wilcoxon test
between D0 and D56.
Change from baseline Arm A p Arm B p Arm C p Arm D p
Glucose (mg/dL) 2.13% 0.03 0% 0.70 4.35% <0.01 þ0.98% 0.15
HOMA-IR 17.07% 0.14 7.94% 0.26 22.13% 0.02 2.87% 0.50
Insulin (mU/mL) 10.00% 0.26 2.81% 0.10 20.40% 0.04 1.72% 0.60
CL/B ratio þ26.40% 0.48 44.05% 0.70 þ14.30% 0.80 þ78.80% 0.03
Table 4
Clustering of the subjects according to their baseline inflammation status and dietary arm.
Cluster n Age, mean (S.D.) Arm A (n) Arm B (n) Arm C (n) Arm D (n)
Low inflammation 51 69.5 (3.8) 13 10 14 14
Medium inflammation 69 70.9 (3.9) 16 20 16 17
R. Ostan et al. / Clinical Nutrition xxx (2015) 1e7 5Fibrinogen concentration decreased significantly in Arm C
(RISTOMED diet þ AISA) compared to Arm A (RISTOMED diet) and
Arm D (RISTOMED diet þ Argan oil) (p ¼ 0.04, Fig. 2).
The differences between D0 and D56 were then analyzed in
each arm of dietary intervention.
ESR decreased significantly in each arm (Arm A: p¼ 0.02, Arm B:
p ¼ 0.046, Arm C: p ¼ 0.02, Arm D: p ¼ 0.01; Fig. 3).
Glucose decreased significantly in Arm A (2.13%, p ¼ 0.03) and
in Arm C (4.35%, p¼ 0.005). Insulin (20.4%, p¼ 0.04) and HOMA-
IR (22.13%, p ¼ 0.02) also significantly decreased in Arm C and the
CL/B ratio significantly increased by 79% (p ¼ 0.03) in Arm D
(Table 3).3.2. Analysis according to the inflammation status at baseline
As mentioned above, two-step cluster analysis based on avail-
able inflammatory parameters (ESR, hsCRP, fibrinogen, TNF-a and
IL-6) at baseline (D0) identified two clusters of older subjects with
low or mediumehigh level of inflammation (Table 4). The “low
inflammation” cluster consisted of 51 subjects (mean age
69.5 ± 3.76 yrs, 23 males and 28 females). The “mediumehigh
inflammation” cluster consisted of 69 subjects (mean age
70.9 ± 3.93 yrs, 27 males and 42 females). Inflammatory parame-
ters (except TNF-a) were significantly higher in subjects belonging
to the mediumehigh inflammation cluster compared to subjects in
the low inflammation cluster (Table 5).
The effects on dietary interventions were then analyzed ac-
cording to the inflammation status of the subjects in each arm of
dietary intervention.
In the low inflammation cluster, minor response to the dietary
interventions was seen. The only significant change, comparing the
four arms by KruskaleWallis analysis, was increased fibrinogen
levels in Arm D (þ29.9% compared to all other groups, p ¼ 0.03).
The percentage of variation between D0 and D56was indeed highly
significant in this group (paired Wilcoxon test, p ¼ 0.007). No sig-
nificant changes in fibrinogen levels were seen in the other arms.
Within arms analyses by pairedWilcoxon tests further showed that
ESR significantly decreased in Arm A (37; 6%, p ¼ 0.03), and that
glucose decreased in Arm C (6.3%, p ¼ 0.005, data not shown).Table 5
Definition of the “low” and “mediumehigh” inflammation clusters. Data are expressed a
Cluster ESR (mm/h) HsCRP (mg/L)
Low Inflammation 8.1 (2e25) 1.2 (0.2e9.3)
Medium-high Inflammation 30 (6e90) 2.7 (0.3e25.2)
p <0.0001 <0.0001
Please cite this article in press as: Ostan R, et al., Impact of diet and nutra
from the RISTOMED study, an open-label randomized control trial, ClinicIn the mediumehigh inflammation cluster, the percentages of
variation between D0 and D56, tested between arms by a Krus-
kaleWallis test, showed that the CL/B ratio (p ¼ 0.03) and IL-6
levels (p ¼ 0.04) were significantly different (Fig. 4). Indeed, the
CL/B ratio was significantly decreased in Arm B (46.2%) compared
to Arms C (þ95.5%) and D (þ83.2%) and IL-6 levels were signifi-
cantly decreased in Arm C (26.3%) compared to Arms A (þ17.3%)
and B (þ15.9%).
Within arms analyses by paired Wilcoxon tests further showed
that ESR decreased significantly in Arm B (27%, p ¼ 0.049) and in
Arm D (49%, p ¼ 0.009) while the CL/B ratio increased signifi-
cantly in Arm D (þ83%, p¼ 0.008) and C (þ95.5%, p¼ 0.04, data not
shown). By contrast, inflammatory markers (fibrinogen p ¼ 0.015;
IL-6, p¼ 0.009) and insulin resistance parameters (insulin, p¼ 0.05;
HOMA-IR, p ¼ 0.048) significantly decreased in Arm C (Fig. 5).
4. Discussion
Observational studies have examined the association of the
Mediterranean diet with inflammatory markers in healthy adults,
reporting that this dietary regimen is able to reduce the expression
of pro-inflammatory and proatherogenic genes in elderly people
[20e22].
The innovative aspect of the European study RISTOMED was to
design diets combining traditional foods and recipes with nutra-
ceutical compounds allowing to assess their effectiveness in the
context of a personalized balanced Mediterranean diet, the RIS-
TOMED diet.
Here we show that RISTOMED diet and nutraceutical supple-
mentation can significantly modulate inflammation and insulin
resistance parameters, especially in healthy older people with a
medium/high inflammatory status. Indeed, there is evidence in the
literature that glucose metabolism and the inflammatory status are
closely related [23]. Of note, among inflammation related param-
eters, we also considered gut microbiota modifications induced by
dietary interventions and supplementation tested.
The anti-inflammatory effect of the RISTOMED diet, with or
without supplementation, translated in a significant decrease of
ESR in all arms. This parameter is a nonspecific indicator of infec-
tion and tissue injury often used to monitor chronic inflammations median (range). Statistical analyses were performed by ManneWhitney test.
Fibrinogen (mg/dL) TNF-a (pg/mL) IL-6 (pg/mL)
295 (180e420) 0.7 (0e18) 7.3 (0.01e18)
419 (299e710) 1 (0e723) 14.7 (2.7e367)
<0.0001 0.1 <0.0001
ceutical supplementation on inflammation in elderly people. Results
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Fig. 4. Percentages of variation of CL/B and IL-6 between D0 and D56 in the mediumehigh inflammation cluster in each arm of dietary intervention. A ¼ RISTOMED diet,
B ¼ RISTOMED diet þ VSL#3, C ¼ RISTOMED diet þ AISA, D ¼ RISTOMED diet þ Argan oil. Statistical analyses were performed by KruskaleWallis test; *p < 0.05.
R. Ostan et al. / Clinical Nutrition xxx (2015) 1e76and response to treatment in inflammatory diseases [24]. However,
we did not find changes in hsCRP levels after the dietary in-
terventions. A recent paper showed that CRP and the proteins that
contribute to the ESR, such as fibrinogen, alpha-2 macroglobulin
and immunoglobulins have distinct time courses and kinetics.
Thus, CRP can rise and then fall at a different rate than ESR
explaining the disagreements between these measures [25].
RISTOMED diet supplemented with natural d-Limonene
extracted from orange peel decreased significantly fibrinogen
levels. Of interest, this dietary and nutraceutical intervention
affected significantly the largest number of parameters, with a
major impact on insulin resistance markers.
When the subjects were further subdivided according to their
baseline inflammatory profile, it is notable that only very few pa-
rameters were modified by the RISTOMED diet, stressing the
inability to show an improvement in healthy not inflamed old in-
dividuals, using the inflammatory biomarkers selected in the RIS-
TOMED study. Conversely, for subjects presenting a clear
“inflammageing” profile, RISTOMED diet supplemented with d-
Limonene significantly impacted on both inflammation and insulin
resistance markers.
This study interestingly included investigation of variations of
the microbiome concentrating on Clostridium cluster IV andFig. 5. Significant variations of inflammatory (fibrinogen and IL-6) and insulin resis-
tance parameters (insulin and HOMA-IR) in the mediumehigh inflammation cluster in
Arm C (RISTOMED diet þ AISA) between D0 and D56. Statistical analyses were per-
formed by paired Wilcoxon test between D0 and D56. p values are reported in the text.
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diet supplemented with VSL#3 probiotic blend increased Bifido-
bacteria and supported adequate folate and vitamin B12 concen-
trations decreasing homocysteine levels and suggesting a
protective role for aging associated conditions, e.g. cardiovascular
or neurodegenerative diseases [12]. Here we confirmed that the
RISTOMED diet associated with VSL#3 probiotic blend induced a
decrease of the ratio between Clostridium cluster IV and Bifidobac-
teria, suggesting a better survival of Bifidobacteria spp. Conversely,
the ratio showed a trend for increase in the other arms. When
subdividing the subjects according to their baseline inflammatory
status, striking differences were noted. RISTOMED diet supple-
mented with VSL#3 probiotic blend tended to increase the ratio
between Clostridium cluster IV and Bifidobacteria in the “low
inflammation group” and to lower it in the “mediumehigh
inflammation” group, while RISTOMED diet supplemented with d-
Limonene had the reverse effect. These variations could be
explained by the different targets of probiotics, acting directly on
the intestinal microbiome, and d-Limonene, modifying the intes-
tinal barrier function as reported elsewhere [26].
In conclusion, in spite of the relatively small size of the sub-
groups and dispersion of data, non-parametric analysis allowed to
demonstrate that a balanced Mediterranean dietary regimen can
counteract inflammageing, especially in elderly individuals with
already altered inflammation parameters, on a prevention
perspective. A screening in search of such latent inflammation
might guide towards the most appropriate personalized approach.
It moreover suggests that d-Limonene supplementation in the
context of this dietary intervention could have a beneficial effect on
older people in limiting the negative influence of chronic inflam-
mation as demonstrated in other models [27] and improving in-
sulin resistance parameters.Conflict of interest
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